Rhesus Negative Obstetric Population in Western Australia Receiving Treatment for the Prevention of Sensitisation to the D-Antigen: Comparison of Existing Australian Dosing Regime and a Single 1500IU Dose to Assess Protection from Sensitisation and Patient Compliance

Trial Profile

Rhesus Negative Obstetric Population in Western Australia Receiving Treatment for the Prevention of Sensitisation to the D-Antigen: Comparison of Existing Australian Dosing Regime and a Single 1500IU Dose to Assess Protection from Sensitisation and Patient Compliance

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Apr 2017

At a glance

  • Drugs Anti-D Rh0 immunoglobulin (Primary)
  • Indications Haemolytic disease of newborn; Pregnancy complications
  • Focus Therapeutic Use
  • Acronyms DACTR
  • Most Recent Events

    • 20 Apr 2017 Status changed from recruiting to completed.
    • 26 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top